Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis

被引:24
|
作者
Feng, Nan [1 ]
Guo, Zhi [1 ]
Wu, Xiaokang [1 ]
Tian, Ying [1 ]
Li, Yue [1 ]
Geng, Yan [1 ]
Yu, Yan [2 ]
机构
[1] Xi An Jiao Tong Univ, Dept Clin Lab, Affiliated Hosp 2, 157 West Fifth Rd, Xian 710004, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Publ Hlth, Hlth Sci Ctr, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China
关键词
miR-493-5p; ROCK1; Cisplatin resistance; Non-small cell lung cancer; CIRCULAR RNA; APOPTOSIS;
D O I
10.1186/s12931-021-01840-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Chemoresistance limits the therapeutic effect of cisplatin (DDP) on non-small cell lung cancer (NSCLC). Circular RNAs (circRNAs) function as important regulators in chemoresistance. This study aimed to explore the regulation of circRNA Phosphatidylinositol-4-Phosphate 5-Kinase Type 1 Alpha (circ_PIP5K1A) in DDP resistance. Methods The expression analysis of circ_PIP5K1A, micoRNA-493-5p (miR-493-5p) and Rho Associated Coiled-Coil Containing Protein Kinase 1 (ROCK1) was conducted through reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Cell sensitivity was determined using 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyl tetrazolium bromide (MTT) assay. Cell proliferation and cell viability were evaluated by colony formation assay and MTT assay, respectively. Cell cycle and apoptosis detection was performed via flow cytometry. Cell motility was examined by transwell migration or invasion assay. Dual-luciferase reporter assay was applied to confirm the target binding. ROCK1 protein level was assayed via Western blot. In vivo assay was carried out using xenograft model in mice. Results Circ_PIP5K1A level was abnormally increased in DDP-resistant NSCLC tissues and cells. Silencing circ_PIP5K1A reduced DDP resistance, proliferation, cell cycle progression and cell motility in DDP-resistant NSCLC cells. Circ_PIP5K1A directly interacted with miR-493-5p in NSCLC cells. The function of circ_PIP5K1A was dependent on the negative regulation of miR-493-5p. MiR-493-5p directly targeted ROCK1 and circ_PIP5K1A regulated the ROCK1 level via acting as a sponge of miR-493-5p. Overexpression of miR-493-5p inhibited chemoresistance and cancer progression by downregulating ROCK1 expression in DDP-resistant NSCLC cells. Circ_PIP5K1A regulated DDP sensitivity in vivo via the miR-493-5p/ROCK1 axis. Conclusion These findings suggested that circ_PIP5K1A upregulated the ROCK1 expression to promote DDP resistance and cancer progression in NSCLC by sponging miR-493-5p.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis
    Xu, Yufen
    Tan, Xiaoli
    Yang, Qi
    Fang, Zhixian
    Chen, Wenyu
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (1-2) : 81 - 93
  • [42] Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis
    Sun, Tingting
    Chen, Jing
    Sun, Xuechao
    Wang, Guonian
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [43] miR-532-5p Inhibits Non-Small Cell Lung Cancer Progression In Vivo and In Vitro by Targeting Yin Yang 1
    Li, Song
    Zhu, Chunlin
    Wang, Quandong
    Wen, Yongsi
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2022, 32 (05): : 47 - 61
  • [44] The lncRNA DLX6-AS1/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: A Boolean model of cell death
    Gupta, Shantanu
    Silveira, Daner A.
    Mombach, Jose Carlos M.
    Hashimoto, Ronaldo F.
    NON-CODING RNA RESEARCH, 2023, 8 (04): : 605 - 614
  • [45] lincRNA-p21 inhibits the progression of non-small cell lung cancer via targeting miR-17-5p
    Ao, Xiang
    Jiang, Ming
    Zhou, Jie
    Liang, Hongling
    Xia, Haoming
    Chen, Gang
    ONCOLOGY REPORTS, 2019, 41 (02) : 789 - 800
  • [46] Andrographis modulates cisplatin resistance in lung cancer via miR-155-5p/SIRT1 axis
    Pang, Chong
    Zhang, Tengyue
    Chen, Yulong
    Yan, Bo
    Chen, Chen
    Zhang, Zhenfa
    Wang, Changli
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (03)
  • [47] p32/OPA1 axis-mediated mitochondrial dynamics contributes to cisplatin resistance in non-small cell lung cancer
    Yu, Chun-Xia
    Peng, Zhe-Qing
    Wang, Tao
    Qu, Xin-Hui
    Yang, Ping
    Huang, Shao-Rong
    Jiang, Li-Ping
    Tou, Fang-Fang
    Han, Xiao-Jian
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2024, 56 (01): : 34 - 43
  • [48] Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis
    Guo, Chunhong
    Wang, Hailiang
    Jiang, Housen
    Qiao, Liang
    Wang, Xinli
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (02) : 84 - 95
  • [49] Long non-coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR-514a-3p/ULK1 axis in human non-small cell lung cancer
    Shen, Qiming
    Xu, Zhe
    Xu, Shun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 57 (04) : 967 - 979
  • [50] Circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis
    Yong Cai
    Zhiyi Dong
    Jiying Wang
    World Journal of Surgical Oncology, 20